1-6 of 6
Neta Moskovits
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5054: Synergistic anti-cancer activity of palbociclib in combination with sunitinib in patient-derived xenograft (PDX) models of various human cancers types

Neta Moskovits, Idit Peretz, Eva Chausky, Raisa Meerson, Ella Itzhaki, Noga Marsiano, Nofar Shmuel, Ranny Yaffe, Natalia Edison, Tal Goldman, Salomon Stemmer
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 5054.
https://doi.org/10.1158/1538-7445.AM2020-5054
Published: 15 August 2020
View article titled, Abstract 5054: Synergistic anti-cancer activity of palbociclib in combination with sunitinib in patient-derived xenograft (PDX) models of various human cancers types
Journal Articles

Abstract C45: NT219, a novel bispecific inhibitor of STAT3 and IRS1/2, combined with chemotherapy or MEK inhibitor in gemcitabine-resistant pancreatic tumors, induced tumor regression

Hadas Reuveni, Lana Kupershmidt, Neta Moskovits, Evgeny Solomonov, Salomon M Stemmer, Izhak Haviv
Journal: Cancer Research
Cancer Res (2019) 79 (24_Supplement): C45.
https://doi.org/10.1158/1538-7445.PANCA19-C45
Published: 13 December 2019
View article titled, Abstract C45: NT219, a novel bispecific inhibitor of STAT3 and IRS1/2, combined with chemotherapy or MEK inhibitor in gemcitabine-resistant pancreatic tumors, induced tumor regression
Journal Articles

Abstract 1030: Circulating tumor cells from patients' blood induce tumors in a personalized xenograft mouse model: A functional approach to assess the patients' premetastatic disease state

Netta R. Shraga, Amihai Lieberman, Neta Moskovits, Alejandro Livoff, Evgeny Solomonov, Inbar Ben Shachar, Aron Popovtzer, Salomon M. Stemmer*, Izhak Haviv*
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1030.
https://doi.org/10.1158/1538-7445.AM2018-1030
Published: 01 July 2018
View article titled, Abstract 1030: Circulating tumor cells from patients' blood induce tumors in a personalized xenograft mouse model: A functional approach to assess the patients' premetastatic disease state
Journal Articles

Abstract 2754: NT219, a novel dual inhibitor of STAT3 and IRS1/2, converts immuno-oncology resistant tumors to responders

Lana Kuperschmidt, Hadas Reuveni, Shani Carmi, Neta Moskovits, Netta R. Shraga, Evgeny Solomonov, Ohad Ronen, Salomon Stemmer, Izhak Haviv
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2754.
https://doi.org/10.1158/1538-7445.AM2018-2754
Published: 01 July 2018
View article titled, Abstract 2754: NT219, a novel dual inhibitor of STAT3 and IRS1/2, converts immuno-oncology resistant tumors to responders
Journal Articles

p53 Status in Stromal Fibroblasts Modulates Tumor Growth in an SDF1-Dependent Manner

Yoseph Addadi, Neta Moskovits, Dorit Granot, Guillermina Lozano, Yaron Carmi, Ron N. Apte, Michal Neeman, Moshe Oren
Journal: Cancer Research
Cancer Res (2010) 70 (23): 9650–9658.
https://doi.org/10.1158/0008-5472.CAN-10-1146
Published: 06 December 2010
View article titled, p53 Status in Stromal Fibroblasts Modulates Tumor Growth in an SDF1-Dependent Manner
Open the PDF for p53 Status in Stromal Fibroblasts Modulates Tumor Growth in an SDF1-Dependent Manner in another window
Includes: Supplementary data
Journal Articles

p53 Attenuates Cancer Cell Migration and Invasion through Repression of SDF-1/CXCL12 Expression in Stromal Fibroblasts

Neta Moskovits, Alexander Kalinkovich, Jair Bar, Tsvee Lapidot, Moshe Oren
Journal: Cancer Research
Cancer Res (2006) 66 (22): 10671–10676.
https://doi.org/10.1158/0008-5472.CAN-06-2323
Published: 15 November 2006
View article titled, p53 Attenuates Cancer Cell Migration and Invasion through Repression of SDF-1/CXCL12 Expression in Stromal Fibroblasts
Open the PDF for p53 Attenuates Cancer Cell Migration and Invasion through Repression of SDF-1/CXCL12 Expression in Stromal Fibroblasts in another window